MCM
CAPR icon

MAI Capital Management’s Capricor Therapeutics CAPR Stock Holding History

MAI Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3K Buy
832
+480
+136% +$12.8K ﹤0.01% 2651
2025
Q4 		$10.2K Sell
352
-3,680
-91% -$48.1K ﹤0.01% 2839
2025
Q3 		$29.1K Hold
4,032
– – ﹤0.01% 2229
2025
Q2 		$40K Buy
4,032
+400
+11% +$4.22K ﹤0.01% 1986
2025
Q1 		$34.5K Hold
3,632
– – ﹤0.01% 1936
2024
Q4 		$50.1K Buy
+3,632
New +$63.6K ﹤0.01% 1767

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

MAI Capital Management's CAPR Position: Q1 2026 in Review

MAI Capital Management increased its Capricor Therapeutics (CAPR) stake by 136% in Q1 2026, buying an estimated $12.8K and bringing the position to 832 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

MAI Capital Management first reported a position in CAPR in Q4 2024 and has held it in 6 quarters since. The position peaked at $50.1K in Q4 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • MAI Capital Management held 832 shares of Capricor Therapeutics worth $25.3K as of Q1 2026.
  • MAI Capital Management bought 480 Capricor Therapeutics shares in Q1 2026, an estimated $12.8K.
  • Capricor Therapeutics made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #2651 holding.
  • MAI Capital Management first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • MAI Capital Management's Capricor Therapeutics position peaked at $50.1K in Q4 2024.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.